Search

Your search keyword '"Thyssen, Jacob P"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Thyssen, Jacob P" Remove constraint Author: "Thyssen, Jacob P" Publisher elsevier bv Remove constraint Publisher: elsevier bv
98 results on '"Thyssen, Jacob P"'

Search Results

5. The Proteome of Hand Eczema Assessed by Tape Stripping

7. Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study

9. Drug survival of adalimumab, secukinumab, and ustekinumab in psoriasis as determined by either dose escalation or drug discontinuation during the first 3 years of treatment – a nationwide cohort study

10. Reduced skin microbiome diversity in infancy is associated with increased risk of atopic dermatitis in high-risk children

14. Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies

15. Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis

19. 32496 Efficacy and safety of abrocitinib according to geographies

21. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

22. Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries

26. 27603 Rapid itch relief with abrocitinib predicts later skin clearance: A post hoc analysis vs dupilumab and placebo in JADE COMPARE

27. 28032 Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)

29. 25532 Effects of upadacitinib on patient-reported symptoms of atopic dermatitis: Atopic Dermatitis Symptom Scale (ADerm-SS) results from two pivotal phase 3 studies (MEASURE UP 1 and MEASURE UP 2)

30. 27533 Comparative efficacy and safety of systemic therapies used in adult and adolescent moderate-to-severe atopic dermatitis (AD): A systematic literature review (SLR) and network meta-analysis (NMA)

33. 27237 Effect of abrocitinib vs dupilumab and placebo on patient-reported outcomes (PROs) in moderate-to-severe atopic dermatitis (AD) in JADE COMPARE

34. Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis

36. Rhinitis prevalence and association with atopic dermatitis

42. Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis

48. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

50. Filaggrin Expression and Processing Deficiencies Impair Corneocyte Surface Texture and Stiffness in Mice

Catalog

Books, media, physical & digital resources